Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Phase 1 Recruiting
51 enrolled
Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
Phase 1 Recruiting
42 enrolled
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
Phase 1 Recruiting
60 enrolled
ATLAS
Phase 1 Recruiting
30 enrolled
FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
Phase 1 Recruiting
50 enrolled
METTSEO
Phase 1 Recruiting
15 enrolled
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
Phase 1 Recruiting
50 enrolled
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
Phase 1 Recruiting
54 enrolled
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Phase 1 Recruiting
116 enrolled
Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
Phase 1 Recruiting
58 enrolled
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Phase 1 Recruiting
420 enrolled
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Phase 1 Recruiting
180 enrolled
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Phase 1 Recruiting
30 enrolled
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
76 enrolled
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Phase 1 Recruiting
36 enrolled
AflacST2301
Phase 1 Recruiting
12 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
Phase 1 Recruiting
24 enrolled
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
Phase 1 Recruiting
120 enrolled
T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
Phase 1 Recruiting
40 enrolled
A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
Phase 1 Recruiting
18 enrolled
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Phase 1 Recruiting
52 enrolled
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Phase 1 Recruiting
171 enrolled
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Phase 1 Recruiting
24 enrolled
IMPACT
Phase 1 Recruiting
21 enrolled
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
80 enrolled
Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial
Phase 1 Recruiting
30 enrolled
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
Phase 1 Recruiting
42 enrolled
A Study of MGC026 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
250 enrolled
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Phase 1 Recruiting
157 enrolled
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
Phase 1 Recruiting
158 enrolled
Losartan + Sunitinib in Treatment of Osteosarcoma
Phase 1 Recruiting
41 enrolled
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
Phase 1 Recruiting
58 enrolled
SABRE
Phase 1 Recruiting
18 enrolled
Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
Phase 1 Recruiting
25 enrolled
SLV-154 Treatment of Metastatic Solid Tumors
Phase 1 Recruiting
70 enrolled
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Phase 1 Recruiting
25 enrolled
Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization
Phase 1 Recruiting
18 enrolled
SOLACE
Phase 1 Recruiting
33 enrolled
ACTengine® IMA203 Combined With mRNA-4203
Phase 1 Recruiting
15 enrolled
Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma
Phase 1 Recruiting
18 enrolled
Aflac-NBL-2002
Phase 1 Recruiting
24 enrolled
A Study of CRD3874-SI in People With Solid Tumors
Phase 1 Recruiting
72 enrolled
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Phase 1 Recruiting
102 enrolled
SynKIR-310 for Relapsed/Refractory B-NHL
Phase 1 Recruiting
18 enrolled
KinLET
Phase 1 Recruiting
20 enrolled
ODIN
Phase 1 Recruiting
40 enrolled
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Phase 1 Recruiting
336 enrolled
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Phase 1 Recruiting
56 enrolled
In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma
Phase 1 Recruiting
17 enrolled